Sun Pharmaceutical Industries appoints Dheeraj Sinha as Executive Vice President, Chief Information Officer
Mumbai: Sun Pharmaceutical Industries Limited has appointed Dheeraj Sinha as Executive Vice President and Chief Information Officer effective from April 3, 2024.Sinha replaces Anil Rao, Senior Vice President and Chief Information Officer. Anil Rao resigned due to personal reasons and his last working day with the Company will be April 30, 2024."This is to inform that Mr. Dheeraj Sinha...
Mumbai: Sun Pharmaceutical Industries Limited has appointed Dheeraj Sinha as Executive Vice President and Chief Information Officer effective from April 3, 2024.
Sinha replaces Anil Rao, Senior Vice President and Chief Information Officer. Anil Rao resigned due to personal reasons and his last working day with the Company will be April 30, 2024.
"This is to inform that Mr. Dheeraj Sinha is appointed as Executive Vice President and Chief Information Officer effective from April 3, 2024," the Company stated in a BSE filing.
Sun Pharma is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult-to-make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs), and Intermediates.
Read also: Sun Pharma gets Australian regulatory nod for acne vulgaris treatment Winlevi
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd